Skip to Main Content

Author Details

Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
2004
137
64
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36860655Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals <i>TP53</i> Aneuploidy-driven Metabolic Reprogramming.Cancer Res Commun2023
37952058Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study.NPJ Breast Cancer2023
37574209Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).Clin Cancer Res2023
38046186PAIRWISE NONLINEAR DEPENDENCE ANALYSIS OF GENOMIC DATA.Ann Appl Stat2023
36968228Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population.Cancer Res Commun2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
36697831Author Correction: Genomic basis for RNA alterations in cancer.Nature2023
36798154Diffsig: Associating Risk Factors With Mutational Signatures.bioRxiv2023
36860655Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals <i>TP53</i> Aneuploidy-driven Metabolic Reprogramming.Cancer Res Commun2023
36602784Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials.JAMA Oncol2023
37952058Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study.NPJ Breast Cancer2023
38046186PAIRWISE NONLINEAR DEPENDENCE ANALYSIS OF GENOMIC DATA.Ann Appl Stat2023
37574209Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).Clin Cancer Res2023
36968228Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population.Cancer Res Commun2023
36697831Author Correction: Genomic basis for RNA alterations in cancer.Nature2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
36602784Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials.JAMA Oncol2023
36798154Diffsig: Associating Risk Factors With Mutational Signatures.bioRxiv2023
34737209TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study.Cancer Epidemiol Biomarkers Prev2022
35710340A hierarchical spike-and-slab model for pan-cancer survival using pan-omic data.BMC Bioinformatics2022
35701440Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases.NPJ Breast Cancer2022
35505906BIDIMENSIONAL LINKED MATRIX FACTORIZATION FOR PAN-OMICS PAN-CANCER ANALYSIS.Ann Appl Stat2022
35437570The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.Cancer Epidemiol Biomarkers Prev2022
36077818DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma.Cancers (Basel)2022
35565277Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression.Cancers (Basel)2022
36333289Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.Nat Commun2022
36207342A multi-omics longitudinal study of the murine retinal response to chronic low-dose irradiation and simulated microgravity.Sci Rep2022
35617957Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.Cell Rep Med2022
36129803RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer.Cancer Epidemiol Biomarkers Prev2022
36321309Race and Ancestry in Immune Response to Breast Cancer.Cancer Discov2022
35044810CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.J Clin Oncol2022
34737209TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study.Cancer Epidemiol Biomarkers Prev2022
35034243Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression.Breast Cancer Res Treat2022
35710340A hierarchical spike-and-slab model for pan-cancer survival using pan-omic data.BMC Bioinformatics2022
35617957Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.Cell Rep Med2022
35505906BIDIMENSIONAL LINKED MATRIX FACTORIZATION FOR PAN-OMICS PAN-CANCER ANALYSIS.Ann Appl Stat2022
35437570The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.Cancer Epidemiol Biomarkers Prev2022
35701440Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases.NPJ Breast Cancer2022
35565277Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression.Cancers (Basel)2022
36207342A multi-omics longitudinal study of the murine retinal response to chronic low-dose irradiation and simulated microgravity.Sci Rep2022
36333289Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.Nat Commun2022
36129803RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer.Cancer Epidemiol Biomarkers Prev2022
36321309Race and Ancestry in Immune Response to Breast Cancer.Cancer Discov2022
36077818DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma.Cancers (Basel)2022
35044810CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.J Clin Oncol2022
35034243Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression.Breast Cancer Res Treat2022
32789507An approach for normalization and quality control for NanoString RNA expression data.Brief Bioinform2021
35432688JOINT AND INDIVIDUAL ANALYSIS OF BREAST CANCER HISTOLOGIC IMAGES AND GENOMIC COVARIATES.Ann Appl Stat2021
35465400Molecular analysis of TCGA breast cancer histologic types.Cell Genom2021
34117034Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder Cancer.Clin Cancer Res2021
  • 1 - 50 of 274

Recommended Authors

Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 15
Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 8
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 32
Natalie S Fox
University of California los angeles
Career Start Year 2013
Number of shared co-authors 8
Yari Ciani
University of Trento
Career Start Year 2012
Number of shared co-authors 2
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 9
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 12
Hans Kristian Moen Vollan
F Hoffmann-La Roche Ltd
Career Start Year 2010
Number of shared co-authors 15
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 83
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 24
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 4
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 11
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 7
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 13
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 7
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 7
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 22
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 8
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 64
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 31
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 3
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 10
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 6
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 37
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 7
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 11
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 3
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 32
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 59
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 22

Collaborators

Charles M Perou
Co-authored papers 68
Melissa A Troester
Co-authored papers 31
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers 29
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 23
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 22
Peter W Laird
Van Andel Institute
Co-authored papers 20
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 20
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Co-authored papers 15
Christopher C Benz
Buck Institute for Research on Aging
Co-authored papers 14
Lisa A Carey
Co-authored papers 14
Christina Yau
University of California San Francisco
Co-authored papers 12
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
Tara M Lichtenberg
Co-authored papers 12
Michael I Love
University of North Carolina at Chapel Hill
Co-authored papers 12
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Co-authored papers 12
Jean Claude Zenklusen
National Cancer Institute
Co-authored papers 12
Andrew F Olshan
Co-authored papers 12
Matthew Meyerson
Broad Institute
Co-authored papers 11
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 10
Hui Shen
Van Andel Institute
Co-authored papers 10
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 10
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 10
Reanne Bowlby
Co-authored papers 10
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers 9
David A Wheeler
Baylor College of Medicine
Co-authored papers 9
Cheng Fan
Co-authored papers 9
Toshinori Hinoue
Co-authored papers 9
Ina Felau
National Cancer Institute
Co-authored papers 8
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 8
Jay Bowen
Nationwide Children's Hospital
Co-authored papers 7
Release 1.2